Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 May 31;13(5):889-892.
doi: 10.21037/tau-23-665. Epub 2024 May 17.

Helpful tool or blunt instrument?-the European Association of Urology Biochemical Recurrence Risk Classification as a decision-making tool for salvage radiotherapy

Rohann J M Correa  1 , Lucas C Mendez  1
Affiliations
Editorial

Helpful tool or blunt instrument?-the European Association of Urology Biochemical Recurrence Risk Classification as a decision-making tool for salvage radiotherapy

Rohann J M Correa et al. Transl Androl Urol. .
No abstract available

Keywords: Prostate cancer; biochemical recurrence (BCR); radical prostatectomy; risk classification; salvage radiotherapy (SRT).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-23-665/coif). L.C.M. reports research grants from Terry Fox Research Institute, Academic Medical Organization of Southwestern Ontario (AMOSO) Opportunities, Ride For Dad (London, Ontario), Abbvie CARO Uro-Oncologic Radiation Awards (ACURA), and Academic Medical Organization of Southwestern Ontario (AMOSO) Innovation; has received honoraria from Knights Therapeutics and Tersera; and has participated in a data safety monitoring board for the London Regional Cancer Program, unrelated to the current study. The other author has no conflicts of interest to declare.

Comment on

References

    1. Preisser F, Abrams-Pompe RS, Stelwagen PJ, et al. European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy—A Multicenter Study. Eur Urol 2024;85:164-70. 10.1016/j.eururo.2023.05.038 - DOI - PubMed
    1. Van den Broeck T, van den Bergh RCN, Arfi N, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol 2019;75:967-87. 10.1016/j.eururo.2018.10.011 - DOI - PubMed
    1. Carrie C, Hasbini A, de Laroche G, et al. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial. Lancet Oncol 2016;17:747-56. 10.1016/S1470-2045(16)00111-X - DOI - PubMed
    1. Shipley WU, Seiferheld W, Lukka HR, et al. Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer. N Engl J Med 2017;376:417-28. 10.1056/NEJMoa1607529 - DOI - PMC - PubMed
    1. Xie W, Regan MM, Buyse M, et al. Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer. J Clin Oncol 2017;35:3097-104. 10.1200/JCO.2017.73.9987 - DOI - PMC - PubMed